Pegylated insulin secreting peptide analogue
聚乙二醇化促胰岛素分泌肽类似物
Report date: 2026/03/30 17:02:26
Base Information
Drug NamePegylated insulin secreting peptide analogue
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (IND)
Highest Status in ChinaPending
Originator CompaniesChongqing Fujin Biological Medicine Co Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesN/A
Inactive CompaniesChongqing Fujin Biological Medicine Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A